R. Gill

发表

M. V. L. Campagne, R. Gill, M. L. Campagne, 1998, Neuroscience.

Developmental expression and co-localization of cyclin G1 and the B' subunits of protein phosphatase 2a in neurons.

M. van Lookeren Campagne, C. Prives, K. Okamoto, 1999, Brain research. Molecular brain research.

The pharmacology of excitatory amino acid antagonists in an animal model of stroke

R. Gill, 1994, European Neuropsychopharmacology.

Pharmacology of AMPA antagonists and their role in neuroprotection.

D. Lodge, R. Gill, R. Gill, 1997, International review of neurobiology.

4-(3,4-dihydro-1H-isoquinolin-2yl)-pyridines and 4-(3,4-dihydro-1H-isoquinolin-2-yl)-quinolines as potent NR1/2B subtype selective NMDA receptor antagonists.

E. Pinard, V. Mutel, G. Trube, 2003, Bioorganic & medicinal chemistry letters.

1-Benzyloxy-4,5-dihydro-1H-imidazol-2-yl-amines, a novel class of NR1/2B subtype selective NMDA receptor antagonists.

E. Pinard, V. Mutel, G. Trube, 2003, Bioorganic & medicinal chemistry letters.

Increased expression of cyclin G1 and p21WAF1/CIP1 in neurons following transient forebrain ischemia: Comparison with early DNA damage

R. Gill, M. L. Campagne, 1998, Journal of neuroscience research.

Localization of a susceptibility gene for common forms of stroke to 5q12.

Vilmundur Gudnason, Kari Stefansson, Klaus Lindpaintner, 2002, American journal of human genetics.

Role of Caspase-3 Activation in Cerebral Ischemia-Induced Neurodegeneration in Adult and Neonatal Brain

K. Blomgren, J. Kemp, H. Loetscher, 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Tumor‐suppressor p53 is expressed in proliferating and newly formed neurons of the embryonic and postnatal rat brain: Comparison with expression of the cell cycle regulators p21Waf1/Cip1, p27Kip1, p57Kip2, p16Ink4a, cyclin G1, and the proto‐oncogene bax

M. Lookeren Campagne, R. Gill, 1998, The Journal of comparative neurology.

Pharmacological Characterization of Ro 63-1908 (1-[2-(4-Hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a Novel Subtype-SelectiveN-Methyl-d-Aspartate Antagonist

J. Kemp, J. Kew, E. Pinard, 2002, Journal of Pharmacology and Experimental Therapeutics.

Ultrastructural morphological changes are not characteristic of apoptotic cell death following focal cerebral ischaemia in the rat

R. Gill, M. L. Campagne, 1996, Neuroscience Letters.

Human C-Reactive Protein Increases Cerebral Infarct Size after Middle Cerebral Artery Occlusion in Adult Rats

J. Kemp, C. Sabin, M. Pepys, 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Temporal and spatial gene expression patterns after experimental stroke in a rat model and characterization of PC4, a potential regulator of transcription

U. Certa, A. Roth, R. Gill, 2003, Molecular and Cellular Neuroscience.

2-(3,4-Dihydro-1H-isoquinolin-2yl)-pyridines as a novel class of NR1/2B subtype selective NMDA receptor antagonists.

E. Pinard, V. Mutel, G. Trube, 2003, Bioorganic & medicinal chemistry letters.

2-Styryl-pyridines and 2-(3,4-Dihydro-naphthalen-2-yl)pyridines as Potent NR1/2B Subtype Selective NMDA Receptor Antagonists

E. Pinard, V. Mutel, G. Trube, 2004 .

Parallel Gene Expression Monitoring using Oligonucleotide Probe Arrays of Multiple Transcripts with an Animal Model of Focal Ischemia

U. Certa, R. Gill, M. Soriano, 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Discovery of (R)-1-[2-hydroxy-3-(4-hydroxy-phenyl)-propyl]-4-(4-methyl-benzyl)-piperidin-4-ol: a novel NR1/2B subtype selective NMDA receptor antagonist.

E. Pinard, V. Mutel, G. Trube, 2001, Bioorganic & medicinal chemistry letters.